Literature DB >> 32496569

Advanced malignant melanoma successfully treated with dacarbazine following anti-PD-1/CTLA-4 treatment.

Atsushi Narahira1, Teruki Yanagi1, Shinya Kitamura1, Takuya Maeda1, Hiroo Hata1, Takushi Asano2, Ayako Nozaki2, Tatsuya Kato2, Hidemichi Watari2, Hiroshi Shimizu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32496569     DOI： 10.1111/ijd.14997

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  2 in total

1.  Transcriptomic Profiling Revealed Plexin A2 Downregulation With Migration and Invasion Alteration in Dacarbazine-Treated Primary Melanoma Cells.

Authors:  Anna Tyumentseva; Anton Averchuk; Nadezhda Palkina; Ivan Zinchenko; Anton Moshev; Andrey Savchenko; Tatiana Ruksha
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

2.  New Imidazole-Based N-Phenylbenzamide Derivatives as Potential Anticancer Agents: Key Computational Insights.

Authors:  M Shaheer Malik; Reem I Alsantali; Qazi Mohammad Sajid Jamal; Zaki S Seddigi; Moataz Morad; Meshari A Alsharif; Essam M Hussein; Rabab S Jassas; Munirah M Al-Rooqi; Zainularifeen Abduljaleel; Ahmed O Babalgith; Hatem M Altass; Ziad Moussa; Saleh A Ahmed
Journal:  Front Chem       Date:  2022-01-19       Impact factor: 5.221
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.